137 related articles for article (PubMed ID: 38266938)
1. Cleaning of direct compression continuous manufacturing equipment through displacement of API residues by excipients.
Patel DS; Méndez R; Romañach RJ
Int J Pharm; 2024 Mar; 652():123849. PubMed ID: 38266938
[TBL] [Abstract][Full Text] [Related]
2. Simplified end-to-end continuous manufacturing by feeding API suspensions in twin-screw wet granulation.
Schmidt A; de Waard H; Moll KP; Kleinebudde P; Krumme M
Eur J Pharm Biopharm; 2018 Dec; 133():224-231. PubMed ID: 30291963
[TBL] [Abstract][Full Text] [Related]
3. Continuous manufacturing of a pharmaceutical cream: Investigating continuous powder dispersing and residence time distribution (RTD).
Bostijn N; Van Renterghem J; Vanbillemont B; Dhondt W; Vervaet C; De Beer T
Eur J Pharm Sci; 2019 Apr; 132():106-117. PubMed ID: 30831193
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Near-Infrared and Raman Spectroscopy for In-Line Monitoring of a Low-Drug Load Formulation in a Continuous Manufacturing Process.
Harms ZD; Shi Z; Kulkarni RA; Myers DP
Anal Chem; 2019 Jul; 91(13):8045-8053. PubMed ID: 31140783
[TBL] [Abstract][Full Text] [Related]
5. Cohesive, multicomponent, dense powder flow characterization by NIR.
Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
[TBL] [Abstract][Full Text] [Related]
6. In-line Raman spectroscopic monitoring and feedback control of a continuous twin-screw pharmaceutical powder blending and tableting process.
Nagy B; Farkas A; Gyürkés M; Komaromy-Hiller S; Démuth B; Szabó B; Nusser D; Borbás E; Marosi G; Nagy ZK
Int J Pharm; 2017 Sep; 530(1-2):21-29. PubMed ID: 28723408
[TBL] [Abstract][Full Text] [Related]
7. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
Bakri B; Weimer M; Hauck G; Reich G
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421
[TBL] [Abstract][Full Text] [Related]
8. Managing active pharmaceutical ingredient raw material variability during twin-screw blend feeding.
Stauffer F; Vanhoorne V; Pilcer G; Chavez PF; Schubert MA; Vervaet C; De Beer T
Eur J Pharm Biopharm; 2019 Feb; 135():49-60. PubMed ID: 30582959
[TBL] [Abstract][Full Text] [Related]
9. Process analytical technology for continuous manufacturing tableting processing: A case study.
Pauli V; Roggo Y; Pellegatti L; Nguyen Trung NQ; Elbaz F; Ensslin S; Kleinebudde P; Krumme M
J Pharm Biomed Anal; 2019 Jan; 162():101-111. PubMed ID: 30227355
[TBL] [Abstract][Full Text] [Related]
10. Modulating Sticking Propensity of Pharmaceuticals Through Excipient Selection in a Direct Compression Tablet Formulation.
Paul S; Sun CC
Pharm Res; 2018 Mar; 35(6):113. PubMed ID: 29603027
[TBL] [Abstract][Full Text] [Related]
11. Continuous Feeding and Blending Demonstration with Co-Processed Drug Substance.
Erdemir D; Gawel J; Yohannes B; Yates P; Tang D; Ha K; Breza B; DiMaso E; Abebe A; Zombek J
J Pharm Sci; 2023 Aug; 112(8):2046-2056. PubMed ID: 36462708
[TBL] [Abstract][Full Text] [Related]
12. Assessment of blend uniformity in a continuous tablet manufacturing process.
Sierra-Vega NO; Román-Ospino A; Scicolone J; Muzzio FJ; Romañach RJ; Méndez R
Int J Pharm; 2019 Apr; 560():322-333. PubMed ID: 30763679
[TBL] [Abstract][Full Text] [Related]
13. Manufacturing process transfer to a 30 kg/h continuous direct compression line with real-time composition monitoring.
Waněk A; Menarini L; Giatti F; Kubelka T; Consoli F; Funaro C; Stasiak P; Štěpánek F
Int J Pharm; 2024 May; 656():124100. PubMed ID: 38609059
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical excipients properties and screw feeder performance in continuous processing lines: a Quality by Design (QbD) approach.
Santos B; Carmo F; Schlindwein W; Muirhead G; Rodrigues C; Cabral L; Westrup J; Pitt K
Drug Dev Ind Pharm; 2018 Dec; 44(12):2089-2097. PubMed ID: 30113219
[TBL] [Abstract][Full Text] [Related]
15. Raman spectroscopy as a process analytical technology tool for the understanding and the quantitative in-line monitoring of the homogenization process of a pharmaceutical suspension.
De Beer TR; Baeyens WR; Ouyang J; Vervaet C; Remon JP
Analyst; 2006 Oct; 131(10):1137-44. PubMed ID: 17003862
[TBL] [Abstract][Full Text] [Related]
16. PAT for tableting: inline monitoring of API and excipients via NIR spectroscopy.
Wahl PR; Fruhmann G; Sacher S; Straka G; Sowinski S; Khinast JG
Eur J Pharm Biopharm; 2014 Jul; 87(2):271-8. PubMed ID: 24705126
[TBL] [Abstract][Full Text] [Related]
17. An investigation into the effects of excipient particle size, blending techniques and processing parameters on the homogeneity and content uniformity of a blend containing low-dose model drug.
Alyami H; Dahmash E; Bowen J; Mohammed AR
PLoS One; 2017; 12(6):e0178772. PubMed ID: 28609454
[TBL] [Abstract][Full Text] [Related]
18. Benchtop NIR method development for continuous manufacturing scale to enable efficient PAT application for solid oral dosage form.
Alam MA; Liu YA; Dolph S; Pawliczek M; Peeters E; Palm A
Int J Pharm; 2021 May; 601():120581. PubMed ID: 33839228
[TBL] [Abstract][Full Text] [Related]
19. A framework for the in silico assessment of the robustness of an MPC in a CDC line in function of process variability.
Waeytens R; Van Hauwermeiren D; Grymonpré W; Nopens I; De Beer T
Int J Pharm; 2024 Jun; 658():124137. PubMed ID: 38670472
[TBL] [Abstract][Full Text] [Related]
20. Process analytical technology in continuous manufacturing of a commercial pharmaceutical product.
Vargas JM; Nielsen S; Cárdenas V; Gonzalez A; Aymat EY; Almodovar E; Classe G; Colón Y; Sanchez E; Romañach RJ
Int J Pharm; 2018 Mar; 538(1-2):167-178. PubMed ID: 29355655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
